The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001064392
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
6/08/2026
Date registered
Help: Date registered
27/08/2026
Date last updated
Help: Date last updated
22/09/2026
Date data sharing statement initially provided
Help: Data sharing statement date
27/08/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Health Outcomes Post pregnancy loss: Exercise for Supporting mental and physical health (HOPES) – a pilot randomised control trial
Scientific title
Health Outcomes Post pregnancy loss: Exercise after Stillbirth (HOPES) for supporting mental and physical health– a pilot randomised control trial
Additional trial identifiers [1] 318085 0
HOPES
Universal Trial Number (UTN)
Trial acronym
Related trial records
ACTRN12626000243314/ANZCTR was an early version of this study which did not commence. This earlier version was a single arm study, this updated version is an randomised control trial.

Health condition
Health condition(s) studied:
early pregnancy loss 343110 0
stillbirth 343111 0
neonatal death 343112 0
miscarriage 343113 0
Condition category
Condition code
Reproductive Health and Childbirth 339201 339201 0 0
Fetal medicine and complications of pregnancy

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Participants allocated to the exercise intervention group will undertake a 10-week program consisting of one hour, in-person, small group sessions delivered weekly, with 3 to 5 participants per group. Sessions will be conducted in the gym at the Susan Wakil Health Building, The University of Sydney.

Each session will commence with a 15 minute education component delivered informally and guided by participant discussion. Topics may include the role of exercise in mood, sleep, and body neutrality.

This will be followed by a 45 minute exercise session consisting of:

• 5 minute mindfulness based activity

• 10 minutes of pelvic floor and abdominal muscle separation training

• 30 minutes of structured exercise

The structured exercise component will involve a tailored program of upper and lower body functional exercises prescribed by an Accredited Exercise Physiologist. Exercises will initially use body weight and may progress to resistance bands and/or external weights. Exercise selection, intensity, and progression will be individualised based on each participant's baseline physical capacity, symptom presentation, and response to exercise, as assessed by the supervising exercise professional throughout the program.

Adherence will be monitored using session attendance records completed by the supervising exercise professional. Participant completion of the prescribed exercise activities, including any modifications, missed activities, or missed sessions, will also be documented throughout the intervention period.
Intervention code [1] 334968 0
Rehabilitation
Intervention code [2] 334969 0
Lifestyle
Intervention code [3] 335073 0
Treatment: Other
Description of the comparator or control
Control group (stretching): Participants allocated to the control group will undertake a 10-week program consisting of one hour, in-person, small group stretching based sessions delivered weekly, with 3 to 5 participants per group. Sessions will be conducted in the gym at the Susan Wakil Health Building, The University of Sydney. The standardised stretching program will be developed by accredited exercise professionals, including an Accredited Exercise Physiologist and/or Exercise Scientist. The program will consist of stretching based activities targeting major muscle groups, such as lunges, calf stretches, and shoulder stretches. The stretching program will be delivered in a consistent manner to all participants and will not include individualised exercise prescription or progression.

Sessions will be facilitated by an exercise physiologist or exercise scientist. Adherence will be monitored using session attendance records completed by the supervising exercise professional.
Control group
Active

Outcomes
Primary outcome [1] 346443 0
Composite primary outcome Perceived acceptability: of the exercise program, including program length, session length, session frequency, educational sessions, warm up activities, exercise component, group-based delivery, and perceived impact on mental or physical health assessed using the post-trial survey. There will also be open ended feedback on what the enjoyed most about this program, what aspects could be improved, and a space for the participants to provide information on anything else the research team should know.
Timepoint [1] 346443 0
Following week 10 of the intervention.
Primary outcome [2] 346444 0
Recruitment rate
Timepoint [2] 346444 0
Assessed after week 1 of the intervention.
Primary outcome [3] 346445 0
Assessment completion rate
Timepoint [3] 346445 0
Three time points. baseline, week 5 and following week 10 of the intervention.
Secondary outcome [1] 465858 0
Retention rate
Timepoint [1] 465858 0
Two time points: baseline and following week 10 of the intervention.
Secondary outcome [2] 465859 0
Adverse events
Timepoint [2] 465859 0
Following week 10 of the intervention
Secondary outcome [3] 465860 0
Physical activity levels
Timepoint [3] 465860 0
Three time points. baseline, week 5 and following week 10 of the intervention.
Secondary outcome [4] 465861 0
Self-efficacy to regulate physical activity
Timepoint [4] 465861 0
Three time points. baseline, week 5 and following week 10 of the intervention.
Secondary outcome [5] 465862 0
Body mind Connection
Timepoint [5] 465862 0
Three time points. baseline, week 5 and following week 10 of the intervention.
Secondary outcome [6] 465863 0
Sleep quality
Timepoint [6] 465863 0
Three time points. baseline, week 5 and following week 10 of the intervention.
Secondary outcome [7] 465864 0
Depressive symptoms
Timepoint [7] 465864 0
Three time points. baseline, week 5 and following week 10 of the intervention.
Secondary outcome [8] 465865 0
Anxiety severity
Timepoint [8] 465865 0
Three time points. baseline, week 5 and following week 10 of the intervention.
Secondary outcome [9] 465866 0
Grief symptoms
Timepoint [9] 465866 0
Three time points. baseline, week 5 and following week 10 of the intervention.

Eligibility
Key inclusion criteria
Inclusion criteria

Participants must have experienced an early pregnancy loss (miscarriage), stillbirth, or neonatal death.

For participants who have experienced an early pregnancy loss (miscarriage), the loss must have occurred between two and eight weeks prior to commencing the exercise program.

For participants who have experienced a stillbirth or neonatal death, the loss must have occurred between two and fourteen weeks prior to commencing the exercise program.

Willingness to provide informed consent and willingness to participate and comply with the study requirements.

Ability to speak and understand the English language.

Over 18 years of age.
Minimum age
18 Years
Maximum age
No limit
Sex
Females
Healthy volunteers
No
Key exclusion criteria
Exclusion criteria

Pain associated with perineal tears, fourth-degree tear or surgical sites during activity.

The presence of an postpartum complication (abnormal postpartum bleeding, infection (wound or uterine), retained products of conception, surgical complications not yet resolved.

Any contraindication to exercise, according to the Adult Pre-Exercise Screening System (APSS) screening tool (Exercise & Sport Science Australia, 2021)

Unable to give informed consent.

Unable to communicate sufficiently in the English language.

Reference
Exercise & Sports Science Australia, Fitness Australia, Sports Medicine Australia, & Exercise is Medicine. (2021). Adult pre-exercise screening system (APSS): User guide. https://www.activeandhealthy.nsw.gov.au/assets/pdf/Adult-Pre-Screening-Tool-2021.pdf

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Following confirmation of eligibility and consent, participants will be randomised to one of two groups (detailed below) at the Baseline visit. Randomisation will occur sequentially through computer-generated random numbers and will be disclosed using the REDCap Randomisation Module. A researcher who will not be involved in recruitment or data collection will be responsible for the randomisation and its fidelity. Participants will be randomly allocated to either:

- An exercise group that will engage in 10 x group-based sessions of physical activity.

- An control group that will engage in 10 x group-based sessions of stretching activities
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
computer-generated random sequence
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
Analysis plan
An intention-to-treat analysis will be used, with anyone who started the program will be included in the analysis.

Descriptive statistics will be used to summarise participant characteristics and feasibility outcomes. Feasibility outcomes, including recruitment rate, retention rate, attrition rate, assessment completion, and adverse events, will be reported using proportions, means, and standard deviations where appropriate.

For secondary outcomes, changes in physical and mental health measures over time will be analysed using repeated measures analyses. A linear mixed model will be used to examine the effects of time (baseline, week 5, week 10), and group (intervention vs control).

Missing data will be explored and described, and patterns of missingness will be reported. As this is a feasibility study, analyses of secondary outcomes are exploratory and not powered to detect statistically significant differences. Effect sizes will be reported to inform the design of a future fully powered trial.

For the post-trial reflective survey, closed-ended survey items (for example, Likert scale, multiple choice, and yes or no responses) will be analysed using descriptive statistics, including frequencies, percentages, and measures of central tendency where appropriate, to summarise perceived acceptability and satisfaction with the program. Responses to short-answer items will be analysed using qualitative content analysis. Responses will be reviewed and coded, and common themes relating to participant experiences, perceived strengths, and suggested improvements will be identified and reported.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 29950 0
Royal Prince Alfred Hospital - Camperdown
Recruitment postcode(s) [1] 46313 0
2050 - Camperdown

Funding & Sponsors
Funding source category [1] 322643 0
University
Name [1] 322643 0
The University of Sydney
Country [1] 322643 0
Australia
Primary sponsor type
University
Name
The University of Sydney
Address
Country
Australia
Secondary sponsor category [1] 325571 0
None
Name [1] 325571 0
Address [1] 325571 0
Country [1] 325571 0
Other collaborator category [1] 284050 0
Hospital
Name [1] 284050 0
The Royal Prince Alfred Hospital
Address [1] 284050 0
Country [1] 284050 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 321101 0
Sydney Local Health District Ethics Review Committee (RPAH Zone)
Ethics committee address [1] 321101 0
Ethics committee country [1] 321101 0
Australia
Date submitted for ethics approval [1] 321101 0
29/06/2026
Approval date [1] 321101 0
03/09/2026
Ethics approval number [1] 321101 0
2026/ETH01417

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 152670 0
Prof Kate Edwards
Address 152670 0
The University of Sydney, Susan Wakil Health Building, Western Ave, Camperdown, 2050, New South Wales
Country 152670 0
Australia
Phone 152670 0
+61 2 9351 2598
Fax 152670 0
Email 152670 0
Contact person for public queries
Name 152671 0
Brooke McGregor
Address 152671 0
The University of Sydney, Susan Wakil Health Building, Western Ave, Camperdown, 2050, New South Wales
Country 152671 0
Australia
Phone 152671 0
+61 2 9351 2598
Fax 152671 0
Email 152671 0
Contact person for scientific queries
Name 152672 0
Brooke McGregor
Address 152672 0
The University of Sydney, Susan Wakil Health Building, Western Ave, Camperdown, 2050, New South Wales
Country 152672 0
Australia
Phone 152672 0
+61 2 9351 2598
Fax 152672 0
Email 152672 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: In all reporting, including academic publications and summaries, only aggregated data such as averages or ranges will be presented. No identifiable information will be included.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.